Form 4: Limitless X Holdings CEO Provides $250,000 Loan, Receives Equity and Warrants

Limitless X Holdings Inc. CEO Jaspreet Mathur, through his wholly-owned entity EM1 Capital, LLC, advanced a $250,000 loan to the company in exchange for 500,000 shares of common stock and warrants to purchase an additional 500,000 shares.

Summary

• Jaspreet Mathur, serving as Director, 10% Owner, and Chief Executive Officer of Limitless X Holdings Inc. (LIMX), reported a transaction on July 11, 2025.
• The transaction involved EM1 Capital, LLC, a corporation wholly-owned by Mr. Mathur, advancing a $250,000 loan to Limitless X Holdings Inc.
• As consideration for the loan, EM1 Capital, LLC received 500,000 shares of the issuer's common stock at a price of $0 per share.
• Additionally, EM1 Capital, LLC received warrants to purchase 500,000 shares of the issuer's common stock, with an exercise price of $0.80 per share.
• These warrants are exercisable from July 11, 2025, and expire on July 10, 2030.
• Following the reported transaction, Mr. Mathur's beneficial ownership includes 500,000 common shares indirectly held by EM1 Capital, LLC, 5,927,264 common shares held directly, and 133,333 common shares indirectly held by Limited Performance, Inc.
• Mr. Mathur also beneficially owns 500,000 warrants indirectly through EM1 Capital, LLC.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a capital infusion from an insider is generally a good sign of commitment and provides needed funds, the terms involving the issuance of shares at $0 and warrants at $0.80 introduce potential dilution for existing shareholders. The need for a loan also suggests the company required additional capital.

Positives

• The company received a $250,000 loan, providing a capital infusion.
• The transaction demonstrates a strong commitment from the Chief Executive Officer and a significant insider, Jaspreet Mathur, to the company's financial stability and operations.

Negatives

• The issuance of 500,000 common shares at a price of $0 as consideration for the loan could be dilutive to existing shareholders.
• The issuance of warrants to purchase an additional 500,000 shares at an exercise price of $0.80 introduces potential future dilution if exercised, which could impact per-share metrics.

Risks

• Potential future dilution of existing shareholders' equity if the 500,000 warrants are exercised.
• The company's need for a $250,000 loan from an insider may indicate ongoing capital requirements or financial constraints.

Future Outlook

The document primarily reports a past transaction and does not provide explicit forward-looking statements or guidance beyond the warrant expiration date. The capital infusion may support future operations.

Management Comments

• The transaction reflects the Chief Executive Officer's direct financial support to the company, indicating confidence or a strategic need for capital.

Industry Context

This Form 4 filing details an insider transaction, which is a common occurrence in publicly traded companies. The provision of a loan by a CEO to their company, in exchange for equity and warrants, is a mechanism for capital infusion, often seen when a company requires additional funding or when insiders wish to increase their stake and support the company's financial position.

Comparison to Industry Standards

• While specific comparable companies or projects are not detailed in this filing, insider loans and equity/warrant issuances are standard financing tools. The terms (e.g., $0 price for shares, $0.80 exercise price for warrants) would typically be evaluated against prevailing market prices for the company's stock and the company's financial health at the time of the transaction to assess the fairness and potential dilutive impact compared to similar transactions in the industry.

Related Party Transactions

• The transaction involves Jaspreet Mathur, the Chief Executive Officer, Director, and 10% Owner, providing a $250,000 loan to Limitless X Holdings Inc. through his wholly-owned entity, EM1 Capital, LLC. This constitutes a related-party transaction.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of 500,000 common shares and the future exercise of 500,000 warrants. However, the capital infusion may support the company's operations and long-term value.
• Company: Receives $250,000 in capital, which can be used for operational needs or strategic initiatives.

Next Steps

• The company will utilize the $250,000 loan for its operations.
• The warrants issued are exercisable until July 10, 2030, potentially leading to future share issuances upon exercise.

Key Dates

Keywords

Limitless X Holdings, LIMX, SEC Form 4, insider transaction, Jaspreet Mathur, CEO, loan, equity issuance, warrants, beneficial ownership, capital raise, corporate finance